Catherine Reynolds

1.7k total citations
34 papers, 855 citations indexed

About

Catherine Reynolds is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Catherine Reynolds has authored 34 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in Catherine Reynolds's work include Atrial Fibrillation Management and Outcomes (5 papers), Diabetes Management and Research (5 papers) and Wound Healing and Treatments (4 papers). Catherine Reynolds is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Diabetes Management and Research (5 papers) and Wound Healing and Treatments (4 papers). Catherine Reynolds collaborates with scholars based in United Kingdom, United States and Australia. Catherine Reynolds's co-authors include Sarah Brown, Jane Nixon, E Andrea Nelson, Benjamin A. Lipsky, Moninder Bhogal, Michael Backhouse, Alexandra Wright‐Hughes, Richard Feltbower, C. R. Stephenson and Peter Vowden and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Diabetes Care.

In The Last Decade

Catherine Reynolds

31 papers receiving 828 citations

Peers

Countries citing papers authored by Catherine Reynolds

Since Specialization

Citations

This map shows the geographic impact of Catherine Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Reynolds more than expected).

Fields of papers citing papers by Catherine Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Reynolds. The network helps show where Catherine Reynolds may publish in the future.

Co-authorship network of co-authors of Catherine Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Reynolds. A scholar is included among the top collaborators of Catherine Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Reynolds. Catherine Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiac magnetic resonance imaging-derived atrial fibrosis in patients with pre-atrial fibrillation 2025 ·Open Heart ·(unknown), Ramesh Nadarajah, Raluca Tomoaia, (unknown), Catherine Reynolds, Simon Bennet, (unknown), (unknown), John Camm, Jianhua Wu, Sven Plein, Peter Swoboda, Chris P Gale	0
2	Protocol for the OPTIMSE-1 randomised clinical trial to test specialist-led identification and management of cardio-renal-metabolic-pulmonary disease in machine learning algorithm-detected high-risk community-dwelling individuals 2025 ·BMJ Open ·Ramesh Nadarajah, (unknown), (unknown), Catherine Reynolds, (unknown), (unknown), Adam B. Smith, Chris Hayward, Jianhua Wu, Chris P Gale	0
3	Systematic Review of the Microbiological Performance of Household Water Treatment Technologies 2025 ·Environmental Science & Technology ·Gouthami Rao, (unknown), Catherine Reynolds, (unknown), (unknown), (unknown), Karl G. Linden, Joe Brown	0
4	Phenotypic characterization of people at risk of atrial fibrillation: protocol for the FIND-AF longitudinal cohort study 2024 ·European Journal of Preventive Cardiology ·(unknown), Ramesh Nadarajah, Catherine Reynolds, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Adam Smith, (unknown), Gregory Y H Lip, Peter Swoboda, Jianhua Wu, (unknown)	3
5	Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation 2023 ·Open Heart ·Ramesh Nadarajah, (unknown), Catherine Reynolds, (unknown), (unknown), (unknown), (unknown), (unknown), Gregory Y.H. Lip, David Hogg, (unknown), Jianhua Wu, Chris P Gale	11
6	Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial 2023 ·BMJ ·Chris P Gale, Deborah Stocken, Suleman Aktaa, Catherine Reynolds, (unknown), David Brieger, Kathryn Carruthers, Derek P. Chew, Shaun G. Goodman, Catherine Fernandez, Linda Sharples, Andrew T. Yan, Keith A.A. Fox	10
7	Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial 2022 ·BMJ Open ·(unknown), (unknown), Isabelle L Smith, (unknown), Rubén Mújica-Mota, Andrew Metcalfe, Hamish Simpson, David W. Murray, Dennis McGonagle, Hemant Sharma, Thomas W. Hamilton, David R Ellard, Catherine Fernandez, Catherine Reynolds, Paul Harwood, Julie Croft, Deborah Stocken, Hemant Pandit	6
8	Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial 2022 ·BMJ Open ·Isabelle L Smith, (unknown), Sarah Brown, Catherine Fernandez, Jane Nixon, Catherine Reynolds, Catherine Smith, John T. Lear, (unknown), Cathy Green, Mark Goodfield, Fiona Cowdell, (unknown), Amy Barker, Armando Vargas‐Palacios, Sandy Tubeuf, Miriam Wittmann	2
9	Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction 2020 ·Diabetes and Vascular Disease Research ·Colin Everett, Catherine Reynolds, Catherine Fernandez, Deborah Stocken, Linda Sharples, Thozhukat Sathyapalan, Simon Heller, Robert F. Storey, Ramzi Ajjan	2
10	Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial 2019 ·BMJ Open ·Colin Everett, Keith A.A. Fox, Catherine Reynolds, Catherine Fernandez, Linda Sharples, Deborah Stocken, Kathryn Carruthers, Harry Hemingway, Andrew T. Yan, Shaun G. Goodman, David Brieger, Derek P. Chew, Chris P Gale	28
11	CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England 2018 ·BMJ Open ·E Andrea Nelson, Alexandra Wright‐Hughes, Michael Backhouse, Benjamin A. Lipsky, Jane Nixon, Moninder Bhogal, Catherine Reynolds, Sarah Brown	53
12	Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity 2017 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Debbie Clements, David J. Jackson, (unknown), Charlotte K. Billington, Irshad Soomro, Catherine Reynolds, Timothy Harrison, Sebastian L. Johnston, Dominick Shaw, Simon R. Johnson	52
13	The Effects of Azithromycin in Treatment-Resistant Cough 2016 ·CHEST Journal ·David Hodgson, John R. Anderson, Catherine Reynolds, Janet Oborne, Garry Meakin, Helen D. Bailey, Dominick Shaw, Kevin Mortimer, Tim Harrison	37
14	Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome 2015 ·White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·Simon Bowman, Colin Everett, Stefano Bombardieri, Robert Busch, P. Emery, (unknown), (unknown), Costantino Pitzalis, (unknown), Luke Dawson, (unknown), Nurhan Sutcliffe, Wan‐Fai Ng, (unknown), (unknown), Linda Sharples, Catherine Reynolds, Sue Pavitt	12
15	Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study 2015 ·Thorax ·Tricia M. McKeever, Glenn Hearson, Gemma Housley, Catherine Reynolds, William Kinnear, Tim Harrison, Anne‐Maree Kelly, Dominick Shaw	50
16	A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA) 2015 ·Thorax ·David Hodgson, John R. Anderson, Catherine Reynolds, Garry Meakin, Helen D. Bailey, Ian Pavord, Dominick Shaw, (unknown)	13
17	The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug 2014 ·BMC Musculoskeletal Disorders ·(unknown), Sarah Brown, Ailsa Bosworth, Claire Davies, Paul Emery, Colin Everett, Catherine Fernandez, Joanne Gray, Suzanne Hartley, Claire Hulme, Anne‐Maree Keenan, Christopher McCabe, Anthony C. Redmond, Catherine Reynolds, David A. Scott, Linda Sharples, Sue Pavitt, Maya H Buch	22
18	Embedding CSII therapy in the routine management of diabetes in children: a clinical audit of this service in Leeds 2009 ·Practical Diabetes International ·Fiona Campbell, (unknown), (unknown), Catherine Reynolds, (unknown), Richard Feltbower	5
19	Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread 2005 ·International Immunology ·Rosemary J. Boyton, (unknown), Chloë Marden, (unknown), Catherine Reynolds, (unknown), Hamlata Dewchand, Daniel M. Altmann	22
20	The fourth largest market in the world 1999 ·Tobacco Control ·Catherine Reynolds	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact